Trilogy Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-37
Closed -$6K 381
2018
Q3
$6K Buy
+37
New +$6K ﹤0.01% 379